Teva Said to Pay $250 Million to End Nevada Prop
Post# of 25340
Posted On: 02/22/2012 12:58:57 AM
Teva Said to Pay $250 Million to End Nevada Propofol Cases
Teva Pharmaceutical Industries Ltd. will pay more than $250 million to settle more than 80 lawsuits alleging the drugmaker sold the anesthetic Propofol in a way that led colonoscopy patients to develop hepatitis C, people familiar with the accords said.
(0)
(0)Scroll down for more posts ▼